Teaching Novel Values-Based Skills to Improve Long-Term Weight Loss

Sponsor
The Miriam Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04256850
Collaborator
(none)
480
1
2
55.4
8.7

Study Details

Study Description

Brief Summary

This NIDDK funded R01 project is a randomized controlled clinical trial to compare the efficacy of an intervention based on Acceptance and Commitment Therapy (ACT) and a Self-Regulation (SR) intervention on weight loss maintenance over a 30-month period. All participants will first complete a well-validated online weight loss intervention (months 1-3 of the study). Participants who lose ≥4 kilograms of initial weight will then be randomly assigned to receive ACT or SR, with both conditions consisting of face-to-face, group-based intervention meetings and weekly email contact for 6 months.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Acceptance and Commitment Therapy (ACT)
  • Behavioral: Self-Regulation (SR)
N/A

Detailed Description

Obesity is a major public health problem, and although short-term weight loss is achievable, individuals often regain the majority of weight that was lost. Current approaches have adjusted behavioral prescriptions and lengthened treatment contact in an effort to address this problem, with modest effect. This NIDDK funded R01 project is a randomized controlled clinical trial to compare the efficacy of an intervention based on Acceptance and Commitment Therapy (ACT) and a Self-Regulation (SR) intervention on weight loss maintenance over a 30-month period. All participants will first complete a well-validated online weight loss intervention (months 1-3 of the study). Participants who lose ≥4 kilograms of initial weight will then be randomly assigned to receive ACT or SR, with both conditions consisting of face-to-face, group-based intervention meetings and weekly email contact for 6 months. The ACT intervention will target a novel theoretically derived intervention target, values-consistent behavior, which will help align weight loss goals with personal values and foster internal motivation to continue with weight control efforts. Assessments will be at baseline, post-weight loss/pre-randomization, and then 6, 12, 18, 24, and 30-month follow-up (months from randomization). This project will be conducted at the Weight Control and Diabetes Research Center (WCDRC). The WCDRC is part of the Centers for Behavioral and Preventive Medicine at The Miriam Hospital in Providence, Rhode Island, and the Department of Psychiatry and Human Behavior at the Alpert Medical School of Brown University. This study is significant because it addresses weight loss maintenance - a critical barrier to treating obesity - and results of the study could be used to improve long-term weight loss outcomes and associated health benefits for treatment seeing overweight and obese adults.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
480 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Teaching Novel Values-Based Skills to Improve Long-Term Weight Loss: A Randomized Trial Examining the Efficacy of a Weight Loss Maintenance Intervention Based on Acceptance and Commitment Therapy
Actual Study Start Date :
Feb 19, 2020
Anticipated Primary Completion Date :
Sep 30, 2024
Anticipated Study Completion Date :
Sep 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Acceptance and Commitment Therapy (ACT)

Focuses on addressing cognitive and emotional barriers to successful weight loss maintenance.

Behavioral: Acceptance and Commitment Therapy (ACT)
Teaches acceptance, mindfulness, and values-based skills

Experimental: Self-Regulation (SR)

Focuses on using self-monitoring and self-reinforcement techniques to improve weight loss maintenance.

Behavioral: Self-Regulation (SR)
Teaches monitoring and reinforcement strategies designed to improve motivation and adherence to positive weight loss behavioral prescriptions.

Outcome Measures

Primary Outcome Measures

  1. Weight Loss Maintenance [30 months]

    weight change from randomization to study end

Secondary Outcome Measures

  1. Waist Circumference [30 months]

    change in waist circumference from randomization to study end

  2. Objectively Measured Physical Activity Minutes Per Week [30 months]

    change in objectively measured physical activity from randomization to study end as measured by 7 days of wearing Actigraph accelerometer device

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • English language fluent and literate at the 6th grade level

  • Body mass index (BMI) between 27.5 and 45 kg/m-squared

  • Able to walk 2 city blocks without stopping

  • Has reliable access to a computer with internet access

Exclusion Criteria:
  • Currently participating in another weight loss program

  • Currently taking weight loss medication

  • Has lost ≥5% of body weight in the 6 months prior to enrolling

  • Has been pregnant within the 6 months prior to enrolling

  • Plans to become pregnant within 18 months of enrolling

  • Has a heart condition, chest pain during periods of activity or rest, or loss of consciousness in the 12 months prior to enrolling

  • Has any medical condition that would affect the safety of participating in unsupervised physical activity

  • Has any condition that would result in inability to follow the study protocol, including terminal illness and untreated major psychiatric illness

Contacts and Locations

Locations

Site City State Country Postal Code
1 Weight Control and Diabetes Research Center Providence Rhode Island United States 02903

Sponsors and Collaborators

  • The Miriam Hospital

Investigators

  • Principal Investigator: Jason Lillis, Ph.D., The Miriam Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
The Miriam Hospital
ClinicalTrials.gov Identifier:
NCT04256850
Other Study ID Numbers:
  • R01DK120731
First Posted:
Feb 5, 2020
Last Update Posted:
Apr 23, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 23, 2021